City National Bank’s Novavax NVAX Stock Holding History

City National Bank’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$555K	Sell	3,927 -20,424	-84%	-$4.58M	﹤0.01%	549
2015 Q2	$5.42M	Sell	24,351 -45,901	-65%	-$8.07M	0.04%	258
2015 Q1	$11.6M	Buy	70,252 +16,042	+30%	+$2.6M	0.1%	199
2014 Q4	$6.43M	Buy	54,210 +4,548	+9%	+$475K	0.06%	252
2014 Q3	$4.14M	Buy	49,662 +2,419	+5%	+$219K	0.04%	281
2014 Q2	$4.37M	Buy	47,243 +24,116	+104%	+$2.12M	0.04%	280
2014 Q1	$2.1M	Buy	23,127 +3,052	+15%	+$341K	0.03%	301
2013 Q4	$2.06M	Buy	20,075 +8,516	+74%	+$602K	0.03%	307
2013 Q3	$728K	Sell	11,559 -1,396	-11%	-$78.6K	0.01%	450
2013 Q2	$531K	Buy	+12,955	New	+$561K	0.01%	519

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

City National Bank's NVAX Position: Q3 2015 in Review

City National Bank reduced its Novavax (NVAX) stake by 84% in Q3 2015, selling an estimated $4.58M and leaving 3,927 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

City National Bank first reported a position in NVAX in Q2 2013 and has held it in 10 quarters since. The position peaked at $11.6M in Q1 2015. 190 funds tracked by Wall St. Rank hold NVAX as of Q3 2015.

City National Bank held 3,927 shares of Novavax worth $555K as of Q3 2015.
City National Bank sold 20,424 Novavax shares in Q3 2015, an estimated $4.58M.
Novavax made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #549 holding.
City National Bank first reported a position in Novavax in Q2 2013 and has held it in 10 quarters since.
City National Bank's Novavax position peaked at $11.6M in Q1 2015.
190 funds tracked by Wall St. Rank held Novavax as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.